{"filing":{"accession_number":"0001492298-26-000023","cik":"0001492298","ticker":"SBRA","company_name":"Sabra Health Care REIT, Inc.","form":"8-K","filing_date":"2026-07-21","report_date":null,"primary_document":"sbra-20260721.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1492298/000149229826000023/sbra-20260721.htm"},"events":[{"id":19009,"run_id":17109,"accession_number":"0001492298-26-000023","anchor_item_number":"7.01","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.75,"summary":"The filing discloses a business update with increased full-year 2026 guidance for Net Income, FFO, Normalized FFO, AFFO, and Normalized AFFO per diluted share, accompanied by detailed reconciliations of non-GAAP measures. While the update also includes portfolio transactions (Avamere re-tenanting and RCA mortgage paydown), the primary disclosure focus is on revised earnings guidance and forward-looking financial projections, which is characteristic of an earnings release or guidance update. The Item 7.01 Regulation FD Disclosure framing and press release format support this classification, though the guidance is forward-looking rather than historical results.","company_name":"Sabra Health Care REIT, Inc.","ticker":"SBRA","filing_date":"2026-07-21","form":"8-K","submitted_at":null,"items":[{"id":17988,"accession_number":"0001492298-26-000023","item_number":"7.01","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"The filing discloses a business update with increased full-year 2026 guidance for Net Income, FFO, Normalized FFO, AFFO, and Normalized AFFO per diluted share, accompanied by detailed reconciliations of non-GAAP measures. While the update also includes portfolio transactions (Avamere re-tenanting and RCA mortgage paydown), the primary disclosure focus is on revised earnings guidance and forward-looking financial projections, which is characteristic of an earnings release or guidance update. The Item 7.01 Regulation FD Disclosure framing and press release format support this classification, though the guidance is forward-looking rather than historical results.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-21T13:05:38.107038+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":17988,"accession_number":"0001492298-26-000023","item_number":"7.01","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"The filing discloses a business update with increased full-year 2026 guidance for Net Income, FFO, Normalized FFO, AFFO, and Normalized AFFO per diluted share, accompanied by detailed reconciliations of non-GAAP measures. While the update also includes portfolio transactions (Avamere re-tenanting and RCA mortgage paydown), the primary disclosure focus is on revised earnings guidance and forward-looking financial projections, which is characteristic of an earnings release or guidance update. The Item 7.01 Regulation FD Disclosure framing and press release format support this classification, though the guidance is forward-looking rather than historical results.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-21T13:05:38.107038+00:00","company_name":"Sabra Health Care REIT, Inc.","ticker":"SBRA","filing_date":"2026-07-21"}]}